Patents by Inventor Scott L. Dax

Scott L. Dax has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240043387
    Abstract: The invention relates to certain substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides, and compositions comprising the same, which in certain embodiments are useful for treating and/or preventing pain in a subject in need thereof.
    Type: Application
    Filed: October 31, 2022
    Publication date: February 8, 2024
    Inventors: Brett A. Tounge, Shariff Bayoumy, Lawrence C. Kuo, Scott L. Dax
  • Publication number: 20220267285
    Abstract: Provided herein are methods of making a thiazoline anti-hyperalgesic, Compound 1, and polymorphs thereof. The methods described herein use inexpensive reagents and are capable of providing Compound 1 in commercial-scale quantities. Also provided are pharmaceutical compositions of Compound 1 suitable for human administration.
    Type: Application
    Filed: October 5, 2021
    Publication date: August 25, 2022
    Applicant: Acadia Pharmaceuticals Inc.
    Inventor: Scott L. Dax
  • Publication number: 20220168279
    Abstract: Methods of treating diabetic neuropathic pain and post-surgical pain are provided. The methods include administering to an individual a therapeutically effective amount of a compound of Formula I (Compound 1). The method can be used to treat diabetic neuropathy arising from any type of nerve damage, and can also be used to treat post-surgical pain arising from any surgical procedure without the side effects associated with widely used analgesics such as opioids. Compound 1 can be formulated into many suitable dosage forms, including oral dosage forms such as tablets.
    Type: Application
    Filed: November 3, 2021
    Publication date: June 2, 2022
    Inventor: Scott L. Dax
  • Publication number: 20220153731
    Abstract: The invention relates to compounds of formula (I), compositions containing the same, and methods for treating and/or diminishing pain in a subject in need thereof. The compounds of formula (I) are effective for treating opioid-induced tachyphylaxis and opioid-induced hyperalgesia.
    Type: Application
    Filed: July 6, 2021
    Publication date: May 19, 2022
    Inventors: SCOTT L. DAX, PASQUALE N. CONFALONE
  • Patent number: 11319290
    Abstract: The invention relates to certain substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides, and compositions comprising the same, which in certain embodiments are useful for treating and/or preventing pain in a subject in need thereof.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: May 3, 2022
    Assignee: Mebias Discovery, Inc.
    Inventors: Brett A. Tounge, Shariff Bayoumy, Lawrence C. Kuo, Scott L. Dax
  • Patent number: 11161826
    Abstract: Provided herein are methods of making a thiazoline anti-hyperalgesic, Compound 1, and polymorphs thereof. The methods described herein use inexpensive reagents and are capable of providing Compound 1 in commercial-scale quantities. Also provided are pharmaceutical compositions of Compound 1 suitable for human administration.
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: November 2, 2021
    Assignee: Acadia Pharmaceuticals Inc.
    Inventor: Scott L. Dax
  • Patent number: 11091473
    Abstract: The invention relates to compounds of formula (I), compositions containing the same, and methods for treating and/or diminishing pain in a subject in need thereof. The compounds of formula (I) are effective for treating opioid-induced tachyphylaxis and opioid-induced hyperalgesia.
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: August 17, 2021
    Assignee: Acadia Pharmaceuticals Inc.
    Inventors: Scott L. Dax, Pasquale N. Confalone
  • Publication number: 20210101868
    Abstract: The invention relates to certain substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides, and compositions comprising the same, which in certain embodiments are useful for treating and/or preventing pain in a subject in need thereof.
    Type: Application
    Filed: September 18, 2020
    Publication date: April 8, 2021
    Inventors: Brett A. Tounge, Shariff Bayoumy, Lawrence C. Kuo, Scott L. Dax
  • Patent number: 10844054
    Abstract: The invention relates to compounds of formula (I), compositions containing the same, and methods for treating and/or diminishing pain in a subject. The compounds of formula (I) are effective for treating opioid-induced tachyphylaxis and opioid-induced hyperalgesia.
    Type: Grant
    Filed: December 27, 2019
    Date of Patent: November 24, 2020
    Assignee: CerSci Therapeutics, Inc.
    Inventors: Scott L. Dax, Pasquale N. Confalone
  • Patent number: 10836728
    Abstract: The invention relates to certain substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides, and compositions comprising the same, which in certain embodiments are useful for treating and/or preventing pain in a subject in need thereof.
    Type: Grant
    Filed: January 17, 2018
    Date of Patent: November 17, 2020
    Assignee: Mebias Discovery, Inc.
    Inventors: Brett A. Tounge, Shariff Bayoumy, Lawrence C. Kuo, Scott L. Dax
  • Publication number: 20200354328
    Abstract: Provided herein are methods of making a thiazoline anti-hyperalgesic, Compound 1, and polymorphs thereof. The methods described herein use inexpensive reagents and are capable of providing Compound 1 in commercial-scale quantities. Also provided are pharmaceutical compositions of Compound 1 suitable for human administration.
    Type: Application
    Filed: March 10, 2020
    Publication date: November 12, 2020
    Inventor: SCOTT L. DAX
  • Publication number: 20200289474
    Abstract: Methods of treating diabetic neuropathic pain and post-surgical pain are provided. The methods include administering to an individual a therapeutically effective amount of a compound of Formula I (Compound 1). The method can be used to treat diabetic neuropathy arising from any type of nerve damage, and can also be used to treat post-surgical pain arising from any surgical procedure without the side effects associated with widely used analgesics such as opioids. Compound 1 can be formulated into many suitable dosage forms, including oral dosage forms such as tablets.
    Type: Application
    Filed: May 28, 2020
    Publication date: September 17, 2020
    Inventor: SCOTT L. DAX
  • Publication number: 20200246317
    Abstract: Methods of treating diabetic neuropathy and pain associated with diabetes are provided. The methods include administering to an individual a therapeutically effective amount of a compound of Formula I (Compound 1). The method can be used to treat diabetic neuropathy pain arising from type I or type II diabetes. Compound 1 can be formulated into many suitable dosage forms, including oral dosage forms such as tablets.
    Type: Application
    Filed: October 16, 2019
    Publication date: August 6, 2020
    Inventor: SCOTT L. DAX
  • Publication number: 20200246316
    Abstract: Methods of treating post-surgical pain are provided. The methods include administering to an individual a therapeutically effective amount of a compound of Formula I (Compound 1). The method can be used to treat post-surgical pain arising from any surgical procedure without the side effects associated with widely used analgesics such as opioids. Compound 1 can be formulated into many suitable dosage forms, including oral dosage forms such as tablets.
    Type: Application
    Filed: June 19, 2019
    Publication date: August 6, 2020
    Inventor: SCOTT L. DAX
  • Publication number: 20200246318
    Abstract: Methods of treating diabetic neuropathic pain and post-surgical pain are provided. The methods include administering to an individual a therapeutically effective amount of a compound of Formula I (Compound 1). The method can be used to treat diabetic neuropathy arising from any type of nerve damage, and can also be used to treat post-surgical pain arising from any surgical procedure without the side effects associated with widely used analgesics such as opioids. Compound 1 can be formulated into many suitable dosage forms, including oral dosage forms such as tablets.
    Type: Application
    Filed: December 19, 2019
    Publication date: August 6, 2020
    Inventor: SCOTT L. DAX
  • Publication number: 20200131170
    Abstract: The invention relates to compounds of formula (I), compositions containing the same, and methods for treating and/or diminishing pain in a subject. The compounds of formula (I) are effective for treating opioid-induced tachyphylaxis and opioid-induced hyperalgesia.
    Type: Application
    Filed: December 27, 2019
    Publication date: April 30, 2020
    Inventors: SCOTT L. DAX, PASQUALE N. CONFALONE
  • Publication number: 20190367499
    Abstract: The invention relates to compounds of formula (I), compositions containing the same, and methods for treating and/or diminishing pain in a subject in need thereof. The compounds of formula (I) are effective for treating opioid-induced tachyphylaxis and opioid-induced hyperalgesia.
    Type: Application
    Filed: May 20, 2019
    Publication date: December 5, 2019
    Inventors: SCOTT L. DAX, PASQUALE N. CONFALONE
  • Publication number: 20190337901
    Abstract: The invention relates to certain substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides, and compositions comprising the same, which in certain embodiments are useful for treating and/or preventing pain in a subject in need thereof.
    Type: Application
    Filed: January 17, 2018
    Publication date: November 7, 2019
    Inventors: BRETT A. TOUNGE, SHARIFF BAYOUMY, LAWRENCE C. KUO, SCOTT L. DAX
  • Patent number: 10294228
    Abstract: The present invention includes compounds that are useful in the prevention and/or treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of preventing and/or treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound and/or composition of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound and/or composition of the invention.
    Type: Grant
    Filed: June 23, 2016
    Date of Patent: May 21, 2019
    Assignee: NEURAD LTD.
    Inventors: Scott L. Dax, James Joseph Mencel, Vita Ozola, Edgars Suna, Kirill Shubin
  • Publication number: 20180141953
    Abstract: The present invention includes compounds that are useful in the prevention and/or treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of preventing and/or treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound and/or composition of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound and/or composition of the invention.
    Type: Application
    Filed: June 23, 2016
    Publication date: May 24, 2018
    Applicant: NEURAD LTD.
    Inventors: Scott L. DAX, James Joseph MENCEL, Vita OZOLA, Edgars SUNA, Kirill SHUBIN